Target intelligence / Profile preview

ACSL6 antisense RNA 1 (ACSL6-AS1)

Target: ACSL6-AS1
Molecular classification: Other (long non-coding RNA, often abbreviated as lncRNA; not a receptor, enzyme, transporter, or transcription factor[7].)

Overview

**ACSL6 antisense RNA 1 (ACSL6-AS1) is a long non-coding RNA transcribed antisense to the ACSL6 gene.** It is distinct from ACSL6, which encodes acyl-CoA synthetase long chain family member 6, a protein involved in fatty acid metabolism in tissues such as brain and retina[7][3][6][8]. There is limited information on ACSL6-AS1 itself: its molecular function, disease relevance, and drug interactions are largely uncharacterized in current databases and literature. Most available research concerns ACSL6 protein-coding gene, which plays roles in lipid metabolism, cancer, and neurological health, but those findings do not apply to the antisense RNA in the context of classic drug targeting[7][2][3]. If you seek data on a receptor/enzyme target, ACSL6 is relevant; however, ACSL6-AS1 is not a therapeutic target according to current biological classification.

Other names: ACSL6-AS1ACSL6 antisense RNA 1

Biological functions

Other (potentially involved in regulatory functions of ACSL6 gene expression via antisense RNA mechanisms; there is no direct evidence of canonical roles like cell cycle, apoptosis, or immune response[7]. Most biological functions described in literature are for ACSL6, not its antisense RNA.)

Disease associations

Other (no established direct role in specific diseases according to current sources; disease associations exist for ACSL6—such as myelodysplastic syndrome, leukemia—but not specifically for ACSL6-AS1[7].)

Beyond the preview

Go deeper on ACSL6 antisense RNA 1 (ACSL6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACSL6 antisense RNA 1 (ACSL6-AS1).

Explore the full profile